AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Compugen to Participate in H.C. Wainwright Global Investment Conference Fireside Chat.
ByAinvest
Thursday, Aug 28, 2025 7:06 am ET1min read
Compugen Ltd., a clinical-stage cancer immunotherapy company, announced that management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference. The chat will be available on-demand on the company's website from September 5, 2025, for 90 days. Compugen is developing two proprietary product candidates, COM701 and COM902, for cancer immunotherapies.
Compugen Ltd., a clinical-stage cancer immunotherapy company, has announced that management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference. The event, scheduled to take place on September 5, 2025, will be available on-demand on the company's website from the same date for 90 days [1].The fireside chat will provide investors and financial professionals with an opportunity to gain insights into Compugen's pipeline and strategic direction. The company is developing two proprietary product candidates, COM701 and COM902, which are in Phase 1 development for cancer immunotherapies. COM701 is a potential first-in-class anti-PVRIG antibody, while COM902 is a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors [2].
In addition to these product candidates, Compugen's therapeutic pipeline includes early-stage immuno-oncology programs aimed at addressing new mechanisms to activate the immune system against cancer. The company is also involved in the development of bispecific and multispecific antibodies, with Rilvegostomig, a PD-1/TIGIT bispecific antibody derived from COM902, currently in Phase 3 development by AstraZeneca [2].
Compugen's shares are listed on the Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For further information, interested parties can contact Yvonne Naughton, Ph.D., Vice President, Head of Investor Relations and Corporate Communications, at ir@cgen.com or +1 (628) 241-0071.
References:
[1] https://www.marketscreener.com/news/compugen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference-ce7c50dfde8af126
[2] https://finance.yahoo.com/news/compugen-present-h-c-wainwright-110000478.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet